Across the United States, independent pharmacies are providing services that extend far beyond traditional retail prescription dispensing.

Many community pharmacies deliver medications to assisted living facilities, prepare compliance packaging for group homes, coordinate medication changes with caregivers, and manage prescriptions for patients who require additional support.

These pharmacies may already be functioning as both retail and long-term care pharmacy providers.

Yet many have never established the contracting and operational infrastructure needed to distinguish their long-term care business from their retail prescription business.

That oversight can have meaningful financial consequences.

A pharmacy may be providing specialized services, absorbing the additional labor and delivery expenses, and receiving reimbursement under ordinary retail contracts.

For pharmacy owners, this raises an important question:

Are you providing long-term care pharmacy services while being reimbursed as a traditional retail pharmacy?

For Ramin Faramarzifar, founder of Rombool Group and an experienced pharmacy owner and operator, this is precisely the type of operational opportunity that independent pharmacy owners should investigate.

With more than 25 years of pharmacy industry experience, Faramarzifar has worked with retail pharmacy, compounding, long-term care services, pharmacy acquisitions, and operational consolidation.

His perspective is that improving pharmacy profitability does not always require opening another location, adding expensive equipment, or significantly increasing prescription volume.

Sometimes the opportunity begins with examining how the pharmacy’s existing business is structured, contracted, and reimbursed.

The Financial Challenge of Serving Long-Term Care Patients Under Retail Contracts

Consider a traditional independent pharmacy that fills retail prescriptions for walk-in customers.

Over time, the pharmacy develops relationships with several assisted living facilities and group homes.

The pharmacy begins providing medication synchronization, multi-dose adherence packaging, scheduled delivery, and coordination with facility personnel.

Its technicians spend additional time organizing prescriptions.

Its pharmacists manage medication changes, verify packaging accuracy, and communicate with healthcare providers.

Its delivery team transports medications to facilities.

These activities can involve costs that exceed those associated with ordinary retail dispensing.

However, if the pharmacy is billing these prescriptions through its existing retail network contracts, the reimbursement may not adequately reflect the specialized services being provided.

The problem is not necessarily prescription volume.

It is the difference between the cost of serving the patient and the compensation the pharmacy receives.

Long-term care pharmacy contracting may provide a way to address that difference.

What Is a Retail/LTC Combo Pharmacy?

A retail/long-term care combination pharmacy, often called a combo pharmacy or combo shop, is an operation that serves both traditional community pharmacy patients and eligible long-term care patients.

Rather than operating two completely separate storefronts, a qualifying pharmacy may be able to maintain separate retail and LTC business classifications within an appropriately structured operation.

The key is establishing the necessary identifiers, contracts, inventory controls, and operational systems.

Under GeriMed’s ComboMed model, a pharmacy may maintain separate retail and LTC NPI and NCPDP identifiers, along with separate wholesaler purchasing accounts.

This structure is commonly described as dual taxonomy.

It allows the pharmacy to distinguish its retail business from its eligible long-term care business for contracting, billing, and purchasing purposes.

However, dual identifiers alone do not establish eligibility for LTC reimbursement or manufacturer purchasing contracts. The pharmacy must satisfy the applicable program, payer, wholesaler, and regulatory requirements.

Why Separate Identifiers Matter

An NPI, or National Provider Identifier, is used to identify healthcare providers in administrative and billing transactions.

An NCPDP pharmacy identifier is used in pharmacy-related data and prescription claims processing.

For a properly established combo pharmacy, separate identifiers may allow eligible LTC claims to be processed under a distinct long-term care network relationship.

The pharmacy’s retail prescriptions can continue through its retail network arrangements.

Its qualifying long-term care prescriptions may be processed through the appropriate LTC arrangements.

This distinction can be financially important because reimbursement terms and purchasing eligibility may differ between the two business categories.

Which Pharmacies Should Consider a Combo Model?

A retail pharmacy should evaluate the opportunity if it already serves patients in settings such as:

• Assisted living facilities.
• Group homes and personal care homes.
• Certain skilled nursing or nursing facilities.
• Intermediate care facilities.
• Residential behavioral health settings.
• Certain hospice or other institutional settings.
• Eligible patients receiving long-term care-level pharmacy services at home.

Not every patient or facility qualifies for the same network terms.

Eligibility depends on payer rules, contracts, patient setting, level of care, and other requirements.

Nevertheless, an independent pharmacy already servicing these populations may have a meaningful opportunity to improve its business structure without abandoning its traditional retail operations.

The Role of GeriMed in Retail/LTC Combo Pharmacy Contracting

One organization worth researching is GeriMed, a group purchasing and pharmacy services organization focused on long-term care pharmacy.

GeriMed offers a program known as ComboMed, designed for independent retail pharmacies that also serve eligible long-term care patients.

According to GeriMed’s published materials, the program supports pharmacies seeking access to LTC network contracts, purchasing opportunities, and operational resources.

Potential benefits include negotiated reimbursement arrangements, access to eligible purchasing contracts, and assistance with certain administrative functions.

For owners unfamiliar with the complexities of long-term care pharmacy contracting, working with an organization that specializes in this area may simplify the evaluation and implementation process.

However, pharmacy owners should review all contractual terms, program costs, eligibility requirements, and anticipated financial benefits before making a decision.

An Important Disclosure

Ramin Faramarzifar and Rombool Group are not affiliated with, sponsored by, or compensated by GeriMed for this article.

GeriMed is discussed solely as an informational example of an organization offering retail/LTC combo pharmacy resources.

Pharmacy owners should conduct independent due diligence and compare available options before entering any agreement.

Opportunity #1: Access to Long-Term Care Dispensing Fees

One of the most important reasons to evaluate LTC contracting is the possibility of reimbursement that more appropriately reflects the cost of specialized dispensing services.

Traditional retail prescriptions and long-term care prescriptions may require different levels of labor, packaging, coordination, and delivery.

For example, a retail prescription might involve dispensing a medication in a standard prescription container.

A long-term care prescription may involve individualized medication packaging, coordination with facility personnel, delivery scheduling, and additional administrative work.

These services create legitimate operating expenses.

Medicare Part D regulations recognize dispensing fees as a component of pharmacy reimbursement. The definition can include appropriate pharmacy costs associated with preparing, packaging, and transferring medications to beneficiaries.

Actual dispensing fees are established through applicable contractual arrangements.

A Hypothetical Reimbursement Comparison

Consider a pharmacy dispensing 2,000 eligible LTC prescriptions per month.

Suppose an evaluation of available contracts shows an average increase of $3 in net reimbursement per qualifying prescription after applicable claim adjustments.

That would represent:

2,000 prescriptions × $3 = $6,000 in additional monthly revenue.

Over 12 months, the annual increase would be $72,000.

Now suppose the net improvement were $5 per eligible prescription.

The potential increase would be $10,000 monthly, or $120,000 annually.

These figures are hypothetical illustrations, not GeriMed reimbursement quotes or guaranteed results.

Actual financial results depend on payer contracts, prescription mix, fees, claim eligibility, and operating costs.

Nevertheless, the example illustrates why relatively modest reimbursement improvements can become financially meaningful when applied to recurring prescription volume.

Opportunity #2: Better Purchasing Economics on Certain Brand-Name Medications

Reimbursement is only one side of pharmacy profitability.

The other is acquisition cost.

For independent pharmacies, the difference between the amount paid to acquire a medication and the amount received through reimbursement can determine whether a prescription is profitable.

Long-term care purchasing programs may offer access to manufacturer agreements or wholesaler arrangements that differ from traditional retail purchasing terms.

GeriMed’s published program materials describe access to purchasing opportunities across several medication and supply categories.

For qualifying pharmacies, this may include more favorable acquisition costs on certain brand-name medications.

Why Separate Wholesaler Accounts Matter

A properly structured combo pharmacy may need distinct retail and LTC wholesaler accounts.

The purpose is to identify and track purchases associated with each business category.

This is particularly important when manufacturer agreements restrict discounted products to specified classes of trade or eligible patient populations.

A pharmacy cannot simply purchase medication through a discounted LTC account and use it indiscriminately for retail prescriptions.

Purchasing and inventory practices must comply with contractual restrictions and applicable law.

GeriMed’s ComboMed model describes a virtual inventory segregation approach that may be supported by compatible pharmacy software and wholesaler systems.

The pharmacy must maintain accurate tracking and documentation.

A Purchasing Example

Suppose a qualifying pharmacy dispenses 500 prescriptions per month involving medications eligible for a particular LTC purchasing arrangement.

If its average net acquisition-cost savings were $8 per prescription, the monthly savings would be:

500 prescriptions × $8 = $4,000.

That represents $48,000 annually.

Again, these figures are hypothetical.

Savings vary by drug, manufacturer, wholesaler, eligibility, purchasing volume, and contractual requirements.

Not every brand-name medication qualifies, and not every purchasing arrangement will improve a pharmacy’s net economics.

Opportunity #3: Medical at Home — A Frequently Overlooked Category

One of the more interesting areas for pharmacy owners to investigate is commonly described as Medical at Home or LTC Pharmacy at Home.

Many patients receive substantial medication-management assistance while continuing to live in private residences.

These individuals may have complex medication regimens, functional limitations, or care needs that require services similar to those provided to residents of institutional long-term care settings.

For example, a patient may receive medications in organized adherence packaging, have prescriptions coordinated with caregivers, and require home delivery.

Certain payer arrangements may recognize the additional pharmacy services required by eligible patients receiving long-term care-level support at home.

This can create an opportunity for pharmacies that already provide intensive medication-management services outside traditional institutions.

Does Every Home-Delivery Patient Qualify?

No.

This is a critical distinction.

Simply delivering prescriptions or providing blister packaging does not automatically convert a retail patient into an LTC patient.

Eligibility may depend on the patient’s level of care, the services provided, the payer’s requirements, and the applicable pharmacy network contract.

A pharmacy must document and verify eligibility before billing under specialized arrangements.

The opportunity is legitimate, but it requires careful compliance.

Why Medical at Home Matters

A growing number of patients receive assistance in their homes rather than relocating to institutional settings.

For independent pharmacies already offering medication synchronization, adherence packaging, and home delivery, this population deserves closer attention.

Owners should ask whether their existing patient services qualify under any available, properly contracted home-based LTC reimbursement arrangements.

The objective is not to reclassify ordinary retail prescriptions.

It is to identify patients whose documented needs and services genuinely satisfy the requirements of an applicable program.

The Importance of Accurate Patient Residence and Pharmacy Service Coding

Proper claims processing requires more than obtaining a second NPI or NCPDP number.

Pharmacies must also ensure that the information submitted on claims accurately reflects the patient, the dispensing pharmacy, and the services provided.

Medicare Part D data distinguishes among multiple patient residence settings, including private homes, skilled nursing facilities, assisted living facilities, and group homes.

It also distinguishes pharmacy service types, including retail and long-term care pharmacies.

Incorrectly identifying a patient’s residence or billing an ineligible prescription under an LTC arrangement can create audit, repayment, and contractual risks.

A pharmacy should establish clear internal procedures for determining eligibility and selecting the correct billing pathway.

This is particularly important for Medical at Home arrangements, where a patient may live in a private residence but receive specialized pharmacy services.

How to Evaluate Whether a Combo Pharmacy Conversion Makes Financial Sense

Before changing its contracting structure, a pharmacy should analyze its existing business.

Start by identifying the prescriptions currently associated with assisted living facilities, group homes, and other eligible settings.

Then determine how those prescriptions are being billed and reimbursed.

A practical financial evaluation should include:

Current reimbursement: What is the pharmacy receiving today for its LTC-related prescriptions?

Potential contracted reimbursement: What would qualifying prescriptions receive under available LTC arrangements?

Purchasing costs: Which medications would qualify for different acquisition-cost arrangements, and what savings are actually available?

Administrative expenses: What additional membership fees, software expenses, implementation costs, and reconciliation requirements would apply?

Operational requirements: Can the pharmacy accurately separate and document retail and LTC activity?

Compliance considerations: Does the proposed structure satisfy payer, manufacturer, wholesaler, and regulatory requirements?

The objective is to calculate the incremental financial benefit after all relevant costs.

Why Increased LTC Profitability May Improve Pharmacy Exit Value

Pharmacy owners considering a future sale should understand the relationship between sustainable earnings and business valuation.

Buyers commonly evaluate pharmacies using earnings measures such as adjusted EBITDA, alongside prescription volume, payer mix, regulatory compliance, and operational risks.

If a pharmacy can legitimately improve its recurring operating income through better contracting and purchasing, that improvement may contribute to enterprise value.

A Hypothetical Valuation Illustration

Suppose a pharmacy implements a compliant retail/LTC combo structure and realizes $100,000 in additional annual EBITDA after all incremental costs.

If a hypothetical buyer values that incremental earnings stream at four times EBITDA, the implied increase in enterprise value would be $400,000.

At five times EBITDA, the implied increase would be $500,000.

These are illustrations, not market valuation guarantees.

A buyer would need to verify that the earnings are recurring, transferable, compliant, and sustainable after the acquisition.

Buyer-specific synergies, payer contracts, manufacturer eligibility, working capital, and transaction terms could materially change the outcome.

The important business principle remains:

Improving sustainable profitability can create value beyond the immediate increase in monthly cash flow.

A Better Pharmacy Business Without Opening Another Location

Many independent pharmacy owners assume growth requires additional locations, more prescriptions, or new service lines.

Sometimes that is true.

But business improvement can also come from examining services already being provided.

A pharmacy that has spent years building relationships with assisted living facilities and group homes may already possess the patient base, delivery infrastructure, packaging equipment, and operational experience needed to support an LTC business.

If those services are being provided under an inefficient contracting arrangement, there may be an opportunity to improve profitability without substantially expanding prescription volume.

This does not mean that every pharmacy should become a combo pharmacy.

It means every pharmacy serving meaningful LTC volume should understand whether its current contracting structure is appropriate.

Ramin Faramarzifar’s Perspective: Understand the Business You Already Have

Through pharmacy ownership and operations, Ramin Faramarzifar has emphasized the importance of evaluating a pharmacy’s underlying economics rather than focusing exclusively on prescription count or gross revenue.

A pharmacy can be busy and still struggle financially.

It can generate significant prescription volume while absorbing excessive packaging, delivery, and administrative expenses.

And it can develop valuable relationships with long-term care facilities without fully understanding the contractual opportunities associated with those services.

The broader lesson is that pharmacy owners should periodically review how every major service line is structured.

Retail prescriptions, long-term care services, compounding, delivery, and medication adherence programs each have distinct economics.

Understanding those differences allows owners to make better decisions about pricing, staffing, contracting, and long-term growth.

For an independent pharmacy already serving assisted living facilities or group homes, evaluating a combo pharmacy model may be a worthwhile strategic exercise.

How to Begin Exploring a Retail/LTC Combo Pharmacy Structure

A pharmacy owner interested in the model should begin with an operational and financial assessment.

First, identify existing LTC patients and determine their actual care settings.

Second, review the pharmacy’s current retail and LTC network participation.

Third, evaluate whether separate NPI and NCPDP identifiers are appropriate and permissible for the proposed structure.

Fourth, discuss wholesaler account requirements and inventory segregation capabilities.

Fifth, request actual reimbursement and purchasing comparisons from prospective contracting organizations.

Sixth, confirm eligibility requirements, documentation standards, and claim submission rules before implementation.

Finally, measure actual financial results after conversion.

The success of a combo pharmacy model should be judged by verified improvements in contribution margin, cash flow, service quality, and regulatory compliance.

Conclusion: A Smarter Contracting Structure Can Be a Competitive Advantage

Independent pharmacy profitability is increasingly dependent on operational efficiency and informed contracting decisions.

For pharmacies serving both retail patients and long-term care populations, the traditional retail-only contracting model may not always reflect the services being provided.

A properly structured retail/LTC combo pharmacy may offer access to specialized reimbursement arrangements, purchasing opportunities, and additional administrative resources.

Medical at Home programs may also deserve consideration for qualifying patients receiving intensive pharmacy support in private residences.

These opportunities are not automatic, and they require careful attention to eligibility, documentation, contractual terms, and regulatory requirements.

However, for the right pharmacy, reviewing the existing business structure may uncover opportunities to improve margins, strengthen cash flow, and potentially increase long-term enterprise value.

Sometimes the next opportunity for pharmacy growth is not a new customer, a new location, or a new prescription. It is recognizing the value of the services the pharmacy is already providing.

About Ramin Faramarzifar and Rombool Group

Ramin Faramarzifar is the founder of Rombool Group and a pharmacy owner and operator with more than 25 years of pharmacy industry experience.

His professional background includes retail pharmacy operations, compounding, long-term care pharmacy services, business acquisitions, and operational management.

His pharmacy ownership experience includes Venice Apothecary & Compounding Center and Sarasota Compounding Pharmacy in Southwest Florida.

Through Rombool Group, Faramarzifar explores strategies involving pharmacy profitability, acquisitions, operational efficiency, business diversification, and long-term enterprise value.

Frequently Asked Questions About Retail/LTC Combo Pharmacies